Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (121-130 of 501) with videos related to

Pageof 51
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 7, 2017
MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibitionTeresa Amaral, Tobias Sinnberg, Friedegund Meier, et al.
The Journal of Investigative Dermatology|November 26, 2002
Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skinMasamoto Murakami, Takaaki Ohtake, Robert A Dorschner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2017
Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulinsIris Spänkuch, Maximilian Gassenmaier, Ioanna Tampouri, et al.
Melanoma Research|March 11, 2010
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Journal of Cancer Research and Clinical Oncology|January 18, 2024
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017Markus Reitmajer, Ulrike Leiter, Lena Nanz, et al.
Cancer|March 26, 2003
Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patientsClaus Garbe, Ulrike Leiter, Ulf Ellwanger, et al.
Molecular & Cellular Proteomics : MCP|October 21, 2021
Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF InhibitionMarisa Schmitt, Tobias Sinnberg, Katrin Bratl, et al.
Plos Medicine|June 6, 2008
Improving melanoma classification by integrating genetic and morphologic featuresAmaya Viros, Jane Fridlyand, Juergen Bauer, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|February 20, 2013
[Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study]Norbert Schäffeler, Karoline Pfeiffer, Eva Maria Grischke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 20, 2011
Oncogenetics of melanoma: basis for molecular diagnostics and therapyLaura Held, Thomas K Eigentler, Friedegund Meier, et al.
Pageof 51

Showing results (121-130 of 501) with videos related to

Sort By:
Pageof 51
European Journal of Cancer (Oxford, England : 1990)|February 7, 2017
MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibitionTeresa Amaral, Tobias Sinnberg, Friedegund Meier, et al.
The Journal of Investigative Dermatology|November 26, 2002
Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skinMasamoto Murakami, Takaaki Ohtake, Robert A Dorschner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2017
Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulinsIris Spänkuch, Maximilian Gassenmaier, Ioanna Tampouri, et al.
Melanoma Research|March 11, 2010
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, et al.
Journal of Cancer Research and Clinical Oncology|January 18, 2024
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017Markus Reitmajer, Ulrike Leiter, Lena Nanz, et al.
Cancer|March 26, 2003
Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patientsClaus Garbe, Ulrike Leiter, Ulf Ellwanger, et al.
Molecular & Cellular Proteomics : MCP|October 21, 2021
Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF InhibitionMarisa Schmitt, Tobias Sinnberg, Katrin Bratl, et al.
Plos Medicine|June 6, 2008
Improving melanoma classification by integrating genetic and morphologic featuresAmaya Viros, Jane Fridlyand, Juergen Bauer, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|February 20, 2013
[Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study]Norbert Schäffeler, Karoline Pfeiffer, Eva Maria Grischke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 20, 2011
Oncogenetics of melanoma: basis for molecular diagnostics and therapyLaura Held, Thomas K Eigentler, Friedegund Meier, et al.
Pageof 51